Allergan: We've been approached by 3rd party about a deal

Allergan says it's been approached by a 3rd party with a buyout offer, reportedly Actavis, as it battles a hostile takeover bid by Valeant Pharmaceuticals and William Ackman's Pershing Square Capital Management.

Actavis, Pershing Square Capital Management, Valeant Pharmaceuticals, Allergan Inc.

News Well, Mergers & Acquisitions, Pharmaceuticals

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/10kRJuL